The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Crystal structure of the µ-opioid receptor bound to a morphinan antagonist
Open accessAbstract
Opium is one of the world’s oldest drugs, and its derivatives morphine and codeine are among the most used clinical drugs to relieve severe pain. These prototypical opioids produce analgesia as well as many undesirable side effects (sedation, apnoea and dependence) by binding to and activating the G-protein-coupled µ-opioid receptor (µ-OR) in the central nervous system. Here we describe the 2.8 Å crystal structure of the mouse µ-OR in complex with an irreversible morphinan antagonist. Compared to the buried binding pocket observed in most G-protein-coupled receptors published so far, the morphinan ligand binds deeply within a large solvent-exposed pocket. Of particular interest, the µ-OR crystallizes as a two-fold symmetrical dimer through a four-helix bundle motif formed by transmembrane segments 5 and 6. These high-resolution insights into opioid receptor structure will enable the application of structure-based approaches to develop better drugs for the management of pain and addiction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
The PyMOL Molecular Graphics System
DeLano, W. L. (2002) · Medical Entomology and Zoology · Cited by 18,147
MolProbity : all-atom structure validation for macromolecular crystallography
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042073 · Cited by 14,115
Crystal structure of the β2 adrenergic receptor–Gs protein complex
Rasmussen, S. G. F., DeVree, B. T., Zou, Y., Kruse, A. C., Chung, K. Y., Kobilka, T. S., Thian, F. S., Chae, P. S., Pardon, E., Calinski, D., et al. (2011) · Nature · doi:10.1038/nature10361 · Cited by 3,009
Self-citationBallesteros, J. A., & Weinstein, H. (1995) · Methods in Neurosciences · doi:10.1016/s1043-9471(05)80049-7 · Cited by 2,999
Endogenous opioid peptides: multiple agonists and receptors
Lord, J. A. H., Waterfield, A. A., Hughes, J., & Kosterlitz, H. W. (1977) · Nature · doi:10.1038/267495a0 · Cited by 2,485
Basic and Clinical Pharmacology
Katzung, B. G. (1982) · Andalas University Repository (Andalas University) · Cited by 1,914
Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists
Wu, B., Chien, E. Y. T., Mol, C. D., Fenalti, G., Liu, W., Katritch, V., Abagyan, R., Brooun, A., Wells, P., Bi, F. C., et al. (2010) · Science · doi:10.1126/science.1194396 · Cited by 1,782
Matthes, H. W. D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dollé, P., et al. (1996) · Nature · doi:10.1038/383819a0 · Cited by 1,722
GPCR Engineering Yields High-Resolution Structural Insights into β 2 -Adrenergic Receptor Function
Rosenbaum, D. M., Cherezov, V., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H.-J., Yao, X.-J., Weis, W. I., Stevens, R. C., et al. (2007) · Science · doi:10.1126/science.1150609 · Cited by 1,336
Self-citationA potent and selective endogenous agonist for the µ-opiate receptor
Zadina, J. E., Hackler, L., Ge, L.-J., & Kastin, A. J. (1997) · Nature · doi:10.1038/386499a0 · Cited by 1,311
G-protein-coupled receptor heterodimerization modulates receptor function
Jordan, B. A., & Devi, L. A. (1999) · Nature · doi:10.1038/21441 · Cited by 1,166
Crystal structure of the ligand-free G-protein-coupled receptor opsin
Park, J. H., Scheerer, P., Hofmann, K. P., Choe, H.-W., & Ernst, O. P. (2008) · Nature · doi:10.1038/nature07063 · Cited by 903
Structure and dynamics of the M3 muscarinic acetylcholine receptor
Kruse, A. C., Hu, J., Pan, A. C., Arlow, D. H., Rosenbaum, D. M., Rosemond, E., Green, H. F., Liu, T., Chae, P. S., Dror, R. O., et al. (2012) · Nature · doi:10.1038/nature10867 · Cited by 811
Self-citationStructure of the human M2 muscarinic acetylcholine receptor bound to an antagonist
Haga, K., Kruse, A. C., Asada, H., Yurugi-Kobayashi, T., Shiroishi, M., Zhang, C., Weis, W. I., Okada, T., Kobilka, B. K., Haga, T., et al. (2012) · Nature · doi:10.1038/nature10753 · Cited by 792
Self-citationHebert, T. E., Moffett, S., Morello, J.-P., Loisel, T. P., Bichet, D. G., Barret, C., & Bouvier, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.27.16384 · Cited by 775
Crystallizing membrane proteins using lipidic mesophases
Caffrey, M., & Cherezov, V. (2009) · Nature Protocols · doi:10.1038/nprot.2009.31 · Cited by 670
Basic and Clinical Pharmacology
Wingard, L. B. (1983) · Anesthesia & Analgesia · doi:10.1213/00000539-198308000-00015 · Cited by 630
Oligomerization of μ- and δ-Opioid Receptors
George, S. R., Fan, T., Xie, Z., Tse, R., Tam, V., Varghese, G., & O'Dowd, B. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000345200 · Cited by 556
Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling
Shukla, A. K., Xiao, K., & Lefkowitz, R. J. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.06.003 · Cited by 418
Sporer, K. A. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-7-199904060-00019 · Cited by 342
Regulation of Opioid Receptor Trafficking and Morphine Tolerance by Receptor Oligomerization
He, L., Fong, J., von Zastrow, M., & Whistler, J. L. (2002) · Cell · doi:10.1016/s0092-8674(02)00613-x · Cited by 339
Conformational cross-talk between α2A-adrenergic and μ-opioid receptors controls cell signaling
Vilardaga, J.-P., Nikolaev, V. O., Lorenz, K., Ferrandon, S., Zhuang, Z., & Lohse, M. J. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.64 · Cited by 264
Design of peptidomimetic .delta. opioid receptor antagonists using the message-address concept
Portoghese, P. S., Sultana, M., & Takemori, A. E. (1990) · Journal of Medicinal Chemistry · doi:10.1021/jm00168a028 · Cited by 258
Facilitation of μ-Opioid Receptor Activity by Preventing δ-Opioid Receptor-Mediated Codegradation
He, S.-Q., Zhang, Z.-N., Guan, J.-S., Liu, H.-R., Zhao, B., Wang, H.-B., Li, Q., Yang, H., Luo, J., Li, Z.-Y., et al. (2011) · Neuron · doi:10.1016/j.neuron.2010.12.001 · Cited by 235
Ligand-regulated oligomerization of β2-adrenoceptors in a model lipid bilayer
Fung, J. J., Deupi, X., Pardo, L., Yao, X. J., Velez-Ruiz, G. A., DeVree, B. T., Sunahara, R. K., & Kobilka, B. K. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.267 · Cited by 181
Self-citationA robust bulk-solvent correction and anisotropic scaling procedure
Afonine, P. V., Grosse‐Kunstleve, R. W., & Adams, P. D. (2005) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444905007894 · Cited by 177
Computational Modeling Approaches to Structure−Function Analysis of G Protein-Coupled Receptors
Fanelli, F., & De Benedetti, P. G. (2005) · Chemical Reviews · doi:10.1021/cr000095n · Cited by 168
Ba 679 BR, A novel long-acting anticholinergic bronchodilator
Disse, B., Reichl, R., Speck, G., Traunecker, W., Rominger, K. L., & Hammer, R. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90312-q · Cited by 165
Key Residues Defining the μ‐Opioid Receptor Binding Pocket: A Site‐Directed Mutagenesis Study
Mansour, A., Taylor, L. P., Fine, J. L., Thompson, R. C., Hoversten, M. T., Mosberg, H. I., Watson, S. J., & Akil, H. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68010344.x · Cited by 123
Morphine-like Opiates Selectively Antagonize Receptor-Arrestin Interactions
Molinari, P., Vezzi, V., Sbraccia, M., Grò, M. C., Riitano, D., Ambrosio, C., Casella, I., & Costa, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.059410 · Cited by 104
G Protein-Coupled Receptor Heteromerization: A Role in Allosteric Modulation of Ligand Binding
Gomes, I., IJzerman, A. P., Ye, K., Maillet, É. L., & Devi, L. A. (2011) · Molecular Pharmacology · doi:10.1124/mol.110.070847 · Cited by 93
Huang, P., Li, J., Chen, C., Visiers, I., Weinstein, H., & Liu‐Chen, L. (2001) · Biochemistry · doi:10.1021/bi010917q · Cited by 85
An Opiate Cocktail that Reduces Morphine Tolerance and Dependence
Li, H., & Whistler, J. L. (2005) · Current Biology · doi:10.1016/j.cub.2005.04.052 · Cited by 84
Fanelli, F., & Benedetti, P. G. D. (2011) · Chemical Reviews · doi:10.1021/cr100437t · Cited by 82
Making Structural Sense of Dimerization Interfaces of Delta Opioid Receptor Homodimers
Johnston, J. M., Aburi, M., Provasi, D., Bortolato, A., Urizar, E., Lambert, N. A., Javitch, J. A., & Filizola, M. (2011) · Biochemistry · doi:10.1021/bi101474v · Cited by 76
[3H]Alvimopan binding to the μ opioid receptor: Comparative binding kinetics of opioid antagonists
Cassel, J. A., Daubert, J. D., & DeHaven, R. N. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.08.008 · Cited by 74
Golebiewska, U. P., Johnston, J. M., Devi, L. A., Filizola, M., & Scarlata, S. (2011) · Biochemistry · doi:10.1021/bi101701x · Cited by 56
Etorphine and Diprenorphine as Immobilizing and Reversing Agents in Captive and Free-Ranging Mammals
Alford, B., Burkhart, R. L., & Johnson, W. P. (1974) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.1974.164.07.702 · Cited by 39
Structural aspects of M 3 muscarinic acetylcholine receptor dimer formation and activation
Hu, J., Thor, D., Zhou, Y., Liu, T., Wang, Y., McMillin, S. M., Mistry, R., Challiss, R. A. J., Costanzi, S., & Wess, J. (2011) · The FASEB Journal · doi:10.1096/fj.11-191510 · Cited by 38
Granier, S., Terrillon, S., Pascal, R., Déméné, H., Bouvier, M., Guillon, G., & Mendre, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405089200 · Cited by 35
Self-citationKurowski, M., Rosenbaum, J. S., Perry, D. C., et al. (1982) · Brain Research · doi:10.1016/0006-8993(82)90068-3 · Cited by 19
Rozenfeld, R., Gomes, I., & Devi, L. A. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-993-2_15 · Cited by 10
Cited by
Molecular signatures of G-protein-coupled receptors
Venkatakrishnan, A. J., Deupi, X., Lebon, G., Tate, C. G., Schertler, G. F., & Babu, M. M. (2013) · Nature · doi:10.1038/nature11896 · Cited by 1,497
Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery
Thomford, N. E., Senthebane, D. A., Rowe, A., Munro, D., Seele, P., Maroyi, A., & Dzobo, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061578 · Cited by 1,241
GPCRdb: an information system for G protein-coupled receptors
Isberg, V., Mordalski, S., Munk, C., Rataj, K., Harpsøe, K., Hauser, A. S., Vroling, B., Bojarski, A. J., Vriend, G., & Gloriam, D. E. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1178 · Cited by 1,072
Structure-Function of the G Protein–Coupled Receptor Superfamily
Katritch, V., Cherezov, V., & Stevens, R. C. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-032112-135923 · Cited by 1,054
Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions
Liu, W., Chun, E., Thompson, A. A., Chubukov, P., Xu, F., Katritch, V., Han, G. W., Roth, C. B., Heitman, L. H., IJzerman, A. P., et al. (2012) · Science · doi:10.1126/science.1219218 · Cited by 945
Metadata
- Authors
- Manglik, A., Kruse, A. C., Kobilka, T. S., Thian, F. S., Mathiesen, J. M., Sunahara, R. K., Pardo, L., Weis, W. I., Kobilka, B. K., & Granier, S.
- Venue
- Nature
- Published
- 2012-03-21
- Volume
- 485
- Issue
- 7398
- Pages
- 321-326
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2083725367
- Cited by
- 1,356
- References
- 45
- FWCI
- 59.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.